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There is an increasing amount of evidence that oxygen radicals produced by activated 
phagocytic cells play an important role in the induction of acute lung injury, which 
in some cases leads to progressive lung injury. The bulk of work in the past several 
years deals with models of acute lung injury in experimental animals. The findings of 
many of these studies have recently been extrapolated to considerations of the adult 
respiratory distress syndome (ARDS) in humans. 
Oxygen radical production by activated phagocytic cells is now a well-known fact,' 
and it is known that a variety of cells, such as neutrophils, eosinophils, monocytes, 
and macrophages, have the ability to produce oxygen radicals upon stimulation. There 
is more evidence that nonphagocytic cells may, under very special circumstances, also 
have the ability to produce oxygen radicals? There is little evidence, however, that 
either platelets or basophils can, upon activation with a variety of stimuli, generate 
these oxygen products, even though secretion of granule products is known to occur. 
Oxygen radical production by phagocytic cells is stimulated by a variety of agonists. 
These agonists include chemotactic peptides and lipids; complement activation prod- 
ucts such as anaphylatoxins and C3b; phorbol myristate acetate; and phagocytic stimuli 
including immune complexes, zymosan particles, and other insoluble materials. Cell 
surface interaction with any of these agonists leads to a cascade of chemical reactions 
which appears to initially involve activation of a cell membrane associated NADPH 
oxidase. This results in the progressive reduction of molecular oxygen, by a sequential 
addition of electrons, to a series of products, as shown in the scheme below: 
0,- e- 
Fez+ ' * OH 
The sequential addition of four electrons to molecular oxygen ultimately results in 
the production of water. It is important to note that the intermediate oxygen radicals 
from the series described above are always present. The most unstable one is the 
hydroxyl radical (-OH), the superoxide anion ( 0;) is moderately unstable, and 
hydrogen peroxide (H,O,) is very stable. It should be emphasized that the conversion 
of hydrogen peroxide to the hydroxyl radical is greatly facilitated by the presence of 
'This work was supported in part by Grants GM18832, GM29507, HL28442, and HL31936 
from the National Institutes of Health. 
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ionic iron. It has been known for some time that in lipid peroxidation reactions iron 
plays a key role.3 Iron may be effective in these reactions because of its ability to 
facilitate the production of hydroxyl radical, although this is a controversial point at 
present. The recognition of a series of products appearing during the progressive 
reduction of molecular oxygen implies that in a given reaction at a given moment 
there will be a mixture of oxygen reduction products, which makes it difficult to 
implicate a single product in a reaction related to tissue injury. Evidence will be 
presented below that hydrogen peroxide and the hydroxyl radical may be the most 
important oxygen products that can be directly linked to tissue injury. 
ARACHIDONATE PRODUCTS AND PHAGOCYTIC CELLS 
Activation of phagocytic cells by chemotactic factors or phagocytic stimuli usually 
leads to a cascade of reactions ultimately resulting in the production of metabolic 
products from arachidonic acid (FIG. 1). Receptor-ligand interaction on the surface 
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FIGURE 1. Arachidonate pathways in phagocytic cells. 
of the phagocytic cell leads to activation of phospholipases, especially phospholipase 
A,, which results in the cleavage of arachidonic acid from the second carbon position 
in the glycerol backbone of a phospholipid. There is some evidence that these reactions 
are also associated concomitantly with the activation of one or more protein kinases, 
which results in phosphorylation of lipomodulin, a naturally occurring inhibitor of 
phospholipases. The ultimate outcome of these reactions is the unrestrained activity 
of phospholipase A,, which causes the appearance of free arachidonic acid within the 
cell. This fatty acid can then undergo metabolism by the cyclooxygenase and the 
lipoxygenase pathways. The former pathway results in the production of the classical 
28 ANNALS NEW YORK ACADEMY OF SCIENCES 
prostaglandins and prostacyclin and thromboxane. The extent to which one or more 
classes of these cyclooxygenase products will be formed depends upon the cell type. 
In the neutrophil, for instance, large amounts of both classical prostaglandins (PGE, 
and PGF,,) and thromboxane (TxA,) are formed, with little or no production of 
prostacyclin (PGI,). In macrophages large amounts of prostaglandins are formed with 
little production of thromboxane. Metabolism of arachidonic acid via the lipoxygenase 
pathway results in the production of a series of mono-HETE compounds and often 
the simultaneous appearance of leukotrienes. Neutrophils tend to produce relatively 
large amounts of leukotriene B, (LTB,) whereas macrophages tend to produce little 
in the way of LTB, and large amounts of the sulfidopeptide leukotrienes LTC,, D,, 
and E4.4*5 
The relationship between the appearance of these products of arachidonate me- 
tabolism and the functional response of the phagocytic cell is not very clear at present. 
Studies in different laboratories have produced conflicting results. The experimental 
approach has usually been either to measure the various arachidonate metabolites and 
correlate their presence with a functional response of the cell or to employ inhibitors, 
the specificity of which is often implied, in order to block either the lipoxygenase 
pathway or the cyclooxygenase pathway and to infer the role of products of each of 
these pathways in the functional response of the stimulated cell. 
Our own studies on the production of arachidonate metabolites in stimulated rat 
neutrophils and the relationship of these products to the cell response are summarized 
in TABLE 1. Neutrophils were prelabeled with tritiated arachidonic acid which was 
fully incorporated into the phospholipid fraction. The cells were then stimulated with 
a variety of agonists: immune complexes, calcium ionophores, zymosan particles, 
chemotactic peptides, and phorbol myristate acetate. The cyclooxygenase inhibitors 
indomethacin, ibuprofen, and piroxicam, as well as the lipoxygenase inhibitors nor- 
dihydroguaiaretic acid (NDGA) and nafazatrom were employed. With reference to 
the specificity of these inhibitors (determined by high pressure liquid chromatography), 
it can be seen that the cyclooxygenase inhibitors reduced the generation of cycloox- 
ygenase products between 40 and 50%. The effectiveness of the different lipoxygenase 
inhibitors varied; the production of cyclooxygenase products was reduced between 1.4 
and 25.8%. When the effects of the same drugs on the generation of lipoxygenase 
products (chiefly 5-HETE and LTB,) were measured, it was found that the cycloox- 
ygenase inhibitors substantially increased (32.5 to 83.2%) the amount of leukotrienes 
produced, whereas the lipoxygenase inhibitors reduced (42.9 to 69.5%) the amounts 
of 5-HETE and LTB, formed. Based upon these data, it appears that cyclooxygenase 
products may “down-regulate” the lipoxygenase pathway; when the cyclooxygenase 
pathway is blocked, either through “substrate shunting” of arachidonic acid into the 
lipoxygenase pathway or via the loss of the negative feedback, there is a marked 
potentiation in the amount of lipoxygenase pathway products formed. 
The effects of these inhibitors on the functional responses of rat neutrophils are 
summarized in TABLE 1. Oxygen radical production was reduced 15 to 43%, and, a 
consistent pattern was demonstrated in the enzyme release response: cyclooxygenase 
pathway inhibitors enhanced it 14 to 18% whereas the lipoxygenase pathway inhibitors 
reduced it 28 to 78%. These data can be interpreted to suggest that there is a linkage 
between lipoxygenase pathway product formation and enzyme secretion in activated 
rat neutrophils and that cyclooxygenase products tend to negatively affect this response. 
On the other hand, no such pattern has been noted with oxygen radical production. 
All inhibitors tend to have inhibitory effects, suggesting that there is a fundamental 
difference between the effects of arachidonate metabolites and their effects in the 
neutrophil responses of enzyme release and oxygen radical generation. These studies 
are described in detail in a recent report4 and are summarized in TABLES 2 & 3. 
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TABLE I. Relationship between Arachidonate Metabolite Production and Functional 
Responses in Stimulated Rat Neutrophils" 
Arachidonate Metabolites Functional Responses 
(Percent Reduction) (Percent Reduction) 
Inhibitor Employed C y c 1 o o x y g e n a s e . 02- Enzyme 
(5-10 pM) Products Leukotrienes Generation Release 
Cyclooxygenase inhibitors 
Indomethacin 50.6 -83.2b 15 -14 
Ibuprofen 40.5 -35.7 19 - 15 
Piroxicam 43.8 -32.5 17 -18 
Lipoxygenase inhibitors 
Nordihydroguaiaretic acid 25.8 69.5 78 
Nafazatrom 1.4 42.9 43 28 
a Neutrophils were stimulated with immune complexes of BSA and of rabbit IgG to BSA; 
this stimulation elicited the functional responses and production of arachidonates. 
Negative numbers indicate enhancement of cell response. 
Some interesting parallels have been noted when arachidonate metabolite pro- 
duction is studied in rat neutrophils undergoing stimulation by a variety of different 
agonists. For instance, stimulation of rat neutrophils by phorbol myristate acetate 
leads to maximal -0; generation but with only trivial amounts of arachidonic products 
being formed, whereas stimulation of rat neutrophils by the chemotactic peptide 
N-formyl-methionyl-leucyl-phenylalanine (FMLP) results in substantial enzyme re- 
lease coupled with substantial arachidonate product formation but with virtually no 
.O; production. Again, these data suggest that there is a dissociation between -0; 
generation and enzyme release and that if arachidonate metabolites are directly in- 
volved in the cell response, it is in the enzyme secretion reaction but not in the response 
of -0; generation. 
Although macrophages in general tend to produce prostaglandins as well as the 
leukotrienes C,, D,, and E,, there is good evidence that a similar parallelism exists 
between cell activation and arachidonate product formation? In studies in mice in 
TABLE 2. Neutrophil Activation, Functional Responses, and Arachidonate Metabolism 
Functional Response 
.0,- Enzyme 
Agonist Generation Release Arachidonate Metabolites 
Phorbol myristate 
Chemotactic peptide 
Calcium ionophores Little Yes Similar to those elicited by FMLP 
IgG-immune complexes Yes Yes Similar to those elicited by FMLP 
acetate Yes Little Few, if any 
(FMLP) No Yes TxB,, 5-HETE, and LTB," 
' ng quantities. 
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TABLE 3. Role of Arachidonate Metabolites in Functional Responses of Rat 
Neutrophils 
Functional Response 
Secretion Generation 
Enzyme .0*- 
.0,- 
Enzyme secretion 
Production of arachidonate 
metabolites" 
No correlation 
- 
__ 
No correlation 
Correlation No correlation 
Cyclooxygenase inhibitors Enhancement Inhibition 
Lipoxygenase inhibitors Inhibition Inhibition 
PGb, TxB,, 5-HETE, and LTB,. 
which T cell-dependent pulmonary granulomas have been investigated, it has been 
demonstrated that the in vivo application of lipoxygenase pathway inhibitors greatly 
diminishes granuloma formation whereas the treatment of animals with cyclooxygenase 
inhibitors of the type described above greatly increases the size of the granulomas. 
As might be expected, treatment of mice with prostaglandin E, markedly diminishes 
the size of the granulomas. Although these studies have been confined to the mouse, 
the interpretation of the role of arachidonate metabolites is similar to that in the study 
of the rat neutrophil (described above). That is to say, cyclooxygenase pathway prod- 
ucts tend to be inhibitory whereas lipoxygenase pathway products enhance the ultimate 
biological response of the activated neutrophil or macrophage. 
MODELS OF ACUTE LUNG INJURY DEPENDENT UPON 
OXYGEN RADICAL FORMATION 
Mediator pathways in models of acute lung injury in which oxygen radical for- 
mation appears to be importantly involved in the ultimate expression of lung injury 
have been studied in a variety of experimental model systems: these are summarized 
in TABLE 4. Three general classifications of model systems can be made. The first 
involves reactions in which neutrophils and complement are both required for the 
ultimate outcome. The second involves reactions in which complement is but neutro- 
phils are not required for the development of tissue damage. The third involves a 
reaction in which neither complement nor neutrophil participation is required for 
acute lung injury. 
Acute lung injury mediated by complement and neutrophils has been well dem- 
onstrated in the case of immune complex deposition involving immunoglobulin G 
(IgG). Whether by the use of rabbit polyclonal antibody to bovine serum albumin 
(BSA) or mouse IgG monoclonal antibody to dinitrophenol (DNP), the resulting 
alveolar and vascular injury associated with deposition of immune complexes requires 
the availability of complement (presumably through its chemotactic factor C5a peptide 
and perhaps other neutrophil-activating products) and neutrophild which, through 
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the formation of oxygen radicals, bring about acute tissue injury.' Superoxide anion 
which can be intercepted by the presence of superoxide dismutase (SOD) results in 
an amplification of the early phases of the inflammatory response, causing the accu- 
mulation of increased numbers of neutrophils at the site of the immune complex 
deposition.8 Additional studies have demonstrated that -0,- and H,O, as well as iron 
participate in the outcome of immune complex-mediated tissue injury? It is likely 
that iron is required because of its ability to facilitate conversion of H,O, to .OH. 
The basis for this conclusion is the recent demonstration that scavengers of hydroxyl 
radical as well as iron chelators will greatly attenuate the damage after IgG immune 
complex deposition in dermal vessels and lungs of rats? Leukocytic myeloperoxidase 
may also contribute to the development of injury through the conversion of H,O, to 
a halide-dependent product such as hypochlorous acid; however, this has not been 
directly demonstrated in viva 
The second model of acute lung injury involving the role of neutrophils and 
complement is that of systemic complement activation: injection of the C3 activator 
isolated from cobra venom into rats produces a prompt and profound activation of 
the complement system, which results in the stimulation of neutrophils and in the 
aggregation and entrapment of neutrophils within the pulmonary interstitial capillary 
network. Neutrophil activation with oxygen radical production results in the injury 
of, and sometimes causes the necrosis of, pulmonary endothelial cells." It has recently 
been demonstrated that the mechanism of injury is probably via hydroxyl radical 
formation; this seems likely because the endothelial cell damage can be greatly atten- 
uated by the presence of catalase, hydroxyl radical scavengers (such as dimethyl 
sulfoxide), and iron chelators (apolactoferrin derived from human breast milk or 
deferoxamine). ' ' 
It has recently been demonstrated that another type of immune complex deposition 
leading to acute lung injury in rat follows a different immunopathogenic mechanism. 
The use of mouse monoclonal immunoglobulin A (IgA) antibody with reactivity to 
DNP has made it possible to demonstrate that immune complex deposition in rat 
lungs leads, in a manner in which neutrophils are not involved, to acute alveolar and 
vascular injury. The reaction, however, is clearly complement dependent! Evidence 
that this is an oxygen radical-related form of injury is emerging even though the 
source of the oxygen radical production has not been determined (K. J. Johnson, B. 
Wilson, and P. A. Ward, unpublished observations). It could be that IgA immune 
complexes acting through some complement activation product are causing oxygen 
radical production from alveolar macrophages, interstitial macrophages, and, perhaps, 
recruited blood monocytes. This remains to be demonstrated. 
The third model system of oxygen radical-dependent acute lung injury involves a 
system that is both complement and neutrophil independent. Phorbol myristate acetate 
TABLE 4. Model Systems of Oxygen Radical-dependent Acute Lung Injury 
Neutrophil- and Complement-dependent Lung Injuly 
Acute immune complex injury by deposition of rabbit polyclonal IgG antibody to BSA or 
Systemic complement activation by injection of C3 activator from cobra venom 
Acute immune complex injury by deposition of mouse monoclonal IgA antibody to DNP 
Acute and progressive lung injury by instillation of phorbol myristate acetate 
mouse monoclonal IgG antibody to DNP 
Neutrophil-dependent and Complement-independent Lung Injuv 
Neutrophil- and Complement-independent Lung Injuiy 
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instilled into the distal airways causes an intense and acute lung injury with the 
alveolar compartment being denuded of the epithelial lining cells. This results not 
only in acute injury with severe intraalveolar hemorrhage and edema but also in 
progressive pulmonary interstitial fibrosis.” It has been demonstrated that neither 
complement nor neutrophil depletion will alter either the acute or the chronic outcome 
of this reaction. On the other hand, the coinstillation of catalase with phorbol myristate 
acetate will prevent both the acute and the progressive damage found in this model 
system. 
The various experimental models described above suggest that oxygen radical 
production from activated phagocytic cells plays an important role in lung injury. 
Interventions designed to intercept these radicals are markedly protective. What de- 
termines chronicity and irreversibility of the lung responses in these models of injury 
is not known, but the observations to date have important implications in a variety 
of lung inflammatory reactions in humans, perhaps the most obvious example being 
the adult respiratory distress syndrome. Extensive additional studies will have to be 
completed before these reactions are fully understood and effective clinical therapeutic 
interventions are developed. 
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